Hartig Drug Company has announced the addition of Nefense® nasal care products at select locations across Iowa, Illinois, and Wisconsin, marking a significant expansion in the availability of drug-free options for daily nasal hygiene. This move responds to growing consumer interest in non-medicated alternatives for respiratory wellness, particularly as concerns about overuse of decongestants persist.
The Nefense lineup includes hypochlorous acid nasal sprays designed for adults, children, and infants, as well as a xylitol-based spray. These products offer a non-medicated approach to nasal care, which is especially relevant for parents seeking gentle solutions for young children and infants. According to the announcement, the sprays are intended for routine nasal hygiene and may help maintain clear airways without the side effects associated with traditional decongestants.
Published randomized clinical research has evaluated the use of low-concentration hypochlorous acid nasal irrigation for chronic sinonasal symptoms and allergic rhinitis, providing a scientific basis for the product category. However, it is important to note that these studies did not test Nefense-branded products directly. Nonetheless, the inclusion of such research underscores the potential benefits of hypochlorous acid in nasal care.
Hartig Drug, a family-owned pharmacy and retail company founded in Dubuque, Iowa, in 1904, continues its tradition of offering health and wellness products with a focus on personalized service. By adding Nefense to its shelves, the company aims to meet the needs of customers seeking alternatives to conventional medications. The products are available now at participating Hartig Drug stores in the three states.
Nefense, based in Dubuque and developed under the direction of Richard Downs, DDS, emphasizes daily nasal hygiene and airway care. The portfolio includes HypoNasal, HypoNasal Junior, HypoBaby, and XyloClean, each formulated to support better breathing. This partnership between two local Iowa companies highlights a shared commitment to community health and innovative wellness solutions.
The availability of these products at Hartig Drug represents a practical application of emerging nasal care science. For consumers, it means more choices in managing nasal health without resorting to medication. As respiratory health remains a priority for many families, the addition of Nefense provides a timely option. To learn more about the full range of Nefense products, visit nefense.com.
